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Risk factors for autogenous infrainguinal bypass
occlusion in patients with prosthetic inflow grafts
Everett Y. Lam, MD, Gregory J. Landry, MD, James M. Edwards, MD, Richard A. Yeager, MD, Lloyd
M. Taylor, MD, and Gregory L. Moneta, MD, Portland, Ore
Objective: In patients with prosthetic inflow (PI) grafts the proximal anastomosis of autogenous infrainguinal bypass
(AIB) can be placed on the PI or on a distal native vessel in the groin. This study was performed to determine the effect
of placement of an AIB proximal anastomotic site in a patient with ipsilateral PI.
Methods: Patients undergoing AIB and PI between January 1990 and July 2002 were included in the study. They were
classified into two groups on the basis of location of the proximal anastomosis. In group 1 the AIB proximal anastomosis
was placed on the PI in the groin, whereas in group 2 the AIB proximal anastomosis was placed on a distal native groin
artery. Patency, limb salvage, and patient survival in the two groups were calculated with the Kaplan-Meier method. The
Cox proportional hazards model was used to determine independent risk factors affecting AIB patency.
Results: Two hundred twenty-nine patients underwent AIB and PI. In group 1, 23 AIBs became thrombosed concurrent
with 26 PI occlusions, and in group 2, 7 AIBs became thrombosed concurrent with 36 PI occlusions (P < .001). Five-year
assisted primary patency, limb salvage, and patient survival in groups 1 and 2 were 50% and 75% (P < .001, log-rank test),
78% and 90% (P  .005, log-rank test), and 56% and 69% (P  NS, log-rank test), respectively. Factors independently
associated with AIB occlusion are hypertension (hazard ratio [HR], 3.41; 95% confidence interval [CI], 1.65-7.05; P 
.001), postoperative warfarin sodium therapy (HR, 1.86; 95% CI, 1.07-3.23; P  .03), continued smoking (HR, 1.72;
95% CI, 0.93-3.18; P .08), AIB arising from PI (HR, 2.38; 95% CI, 1.35-4.18; P .003), and PI occlusion (HR, 3.70;
95% CI, 2.15-6.36; P < .001).
Conclusion: A proximal AIB anastomosis located directly on the PI is an independent risk factor for decreased AIB patency
of equal or greater importance than current smoking, hypertension, or PI occlusion. The proximal anastomosis of an AIB
in a patient with an ipsilateral PI should be placed on a distal native artery. (J Vasc Surg 2004;39:336-42.)
Surgical therapy for patients with multilevel arterial
occlusive disease may require restoration of inflow into the
groin with concomitant or subsequent infrainguinal bypass
procedures. Approximately 25% of patients with multilevel
arterial occlusive disease will require both inflow and out-
flow revascularization to successfully resolve symptoms of
lower extremity ischemia.1-3 In addition, in as many as 50%
of patients who have undergone infrainguinal bypass pro-
cedures symptoms of ischemia will develop as a result of
inflow disease progression,4,5 and will require subsequent
restoration or improvement of arterial inflow.
Multiple factors affect the patency of infrainguinal by-
pass procedures. The importance of symptoms at presenta-
tion, graft material, site of distal anastomosis, previous
bypass surgery, gender, continued smoking, hypercoagula-
bility, renal disease, and diabetes mellitus have been as-
sessed.6-9 Although patients with multilevel arterial occlu-
sive disease are typically older and have more comorbid
conditions,10 long-term patency of infrainguinal bypass
distal to reconstructed inflow is similar to that in distal to
normal arterial inflow, with 4-year assisted primary patency
rates of 62% to 80%.1,11
In patients with prosthetic inflow (PI), the proximal
anastomosis of autogenous infrainguinal bypass (AIB) can
be placed on the PI or on a distal native vessel in the groin.
The site of AIB proximal anastomosis has not been in-
cluded in previous reports describing the outcome of in-
frainguinal bypass distal to reconstructed inflow. The pur-
poses of this study were to determine the effect of the
location of AIB proximal anastomosis in the groin on AIB
patency and to identify risk factors for AIB occlusion in
patients with PI.
METHODS
Patient characteristics. Patients were eligible for in-
clusion in the study if they had undergone elective suprain-
guinal PI procedures (aortofemoral, femorofemoral, il-
iofemoral, axillounifemoral, or axillobifemoral) and
infrainguinal AIB procedures, to treat atherosclerotic oc-
clusive disease, at Oregon Health & Science University or
the Portland Veterans Affairs Medical Center, between
January 1, 1990, and July 1, 2002. In all cases the distal PI
anastomosis and proximal AIB anastomosis were in the
groin.
Patient demographic data and atherosclerotic risk fac-
tors assessed included age, gender, hypertension, coronary
artery disease, diabetes mellitus, hyperlipidemia, chronic
renal insufficiency (serum creatinine concentration 1.5
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mg/dL at two separate determinations), warfarin sodium
therapy, aspirin therapy, and continued smoking during
follow-up. Also recorded were technical factors, including
previous ipsilateral infrainguinal bypass, extraanatomic PI,
alternative vein conduit, infrapopliteal AIB target, location
of proximal AIB anastomosis, simultaneous PI and AIB,
and limb salvage as the indication for the procedure. The
presence or absence of a patent ipsilateral profunda femoris
artery was recorded. Warfarin therapy was initiated in pa-
tients with clinical indications (atrial fibrillation, prosthetic
cardiac valves, venous thrombosis, multiple arterial throm-
boses). All patients receiving warfarin therapy were main-
tained at a goal international normalized ratio between 2
and 3.
All AIB operations were performed with the technique
of reversed vein bypass, as described in previous reports
from our institution.12-14 The conduit of choice is the
ipsilateral greater saphenous vein. If this vein is inadequate,
the contralateral saphenous vein is preferred. If neither vein
is available, the choices, in order of preference, include
composite saphenous vein, arm vein, lesser saphenous vein,
and femoral or popliteal veins. In this study all conduits
other than ipsilateral or contralateral saphenous veins were
considered alternative vein conduit. Bypass grafts were
preferentially tunneled along the anatomic course of the
arteries. The artery with the best appearance at angiography
was selected for the distal anastomotic site.
All patients who fulfilled the inclusion criteria were
included in the study. Patients were classified into two
groups. In group 1 the AIB proximal anastomosis was
placed on the PI in the groin, and in group 2 the AIB
proximal anastomosis arose from a distal native artery in the
groin. The presence of a patent ipsilateral profunda femoris
artery in group 1 was determined on the basis of each
patient’s initial preoperative arteriogram. The choice of
proximal anastomotic site was determined by the attending
surgeon at surgery. Patients were followed up in the Vas-
cular Surgery Clinic at 3-month intervals for the first year
and every 6 months thereafter, with duplex scan graft
surveillance at each visit.
Criteria for identifying an AIB at risk included focal
peak systolic velocity (PSV) greater than 200 cm/s within
the graft or in the outflow or inflow site, prestenotic to
intrastenotic PSV ratio greater than 3.0, uniformly low PSV
less than 45 cm/s throughout the entire graft, interval
decrease in the ankle-brachial index greater than 0.2, and
significant change in clinical status. An arteriogram was
obtained before all vein graft revisions.
Survival data were obtained from the medical record
when available or the Social Security Death Index website
(http://ssdi.genealogy.rootsweb.com/cgi-bin/ssdi.cgi).
Criteria for patency and occlusion were those suggested by
Rutherford et al.15 Graft occlusion was detected with du-
plex ultrasound scanning, arteriography, or both.
Statistical analysis. Atherosclerotic and technical risk
factors in groups 1 and 2 were examined with 2 analysis.
Assisted primary patency, limb salvage, and survival were
determined with the Kaplan-Meier method, and the rates
between the two groups were compared with the log-rank
test. Multivariate analysis was performed with the Cox
proportional hazards model, to compare data for patients in
group 1 with those in group 2. Variables included in the
model were known atherosclerotic and technical risk factors
that affect graft patency, and presence or absence of a
patent ipsilateral profunda femoris artery. Hazard ratios for
graft occlusion, with 95% confidence intervals, were calcu-
lated with the Cox regression model. The SPSS statistical
program (SPSS, Chicago, Ill) was used to perform the
statistical analyses.
The study was approved by the Institutional Review
Board of the Oregon Health & Science University and the
Portland Veterans Affairs Medical Center.
RESULTS
Patients. A total of 229 patients underwent PI and
AIB during the study. There were 59 patients in group 1,
who underwent 64 AIBs. Group 2 consisted of 170 pa-
tients, with 200 AIBs. The mean follow-up period was 29
months (range, 1-165 months) for group 1, and 43 months
(range, 1-156 months) for group 2. In group 1 the ipsilat-
eral profunda femoris artery was patent in 34 limbs (58%),
and was occluded in 25 limbs (43%). The ipsilateral pro-
funda femoris artery in group 2 was patent in 199 limbs
(99.5%), and was occluded in 1 limb (0.5%).
Patient characteristics in groups 1 and 2 are shown in
Table I. More patients in group 1 had coronary artery
disease (66% vs 50%; P  .02) and were current smokers
(70% vs 54%; P  .03) than in group 2. More patients in
group 1 underwent AIB for limb salvage (97% vs 88%; P
.05) than in group 2.
Location of AIB proximal anastomosis. The proxi-
mal anastomosis of all 64 AIBs in group 1 originated from
the PI in the ipsilateral groin. In group 2, 170 (85%) AIBs
originated from the profunda femoris artery, 24 (12%)
Table I. Characteristics of group 1 and group 2 patients
Patient characteristic
Group 1
(n  59)
Group 2
(n  170) P
Age (y) 65.4 66.9 NS
Gender (% male) 67 69 NS
Hypertension (%) 75 64 NS
Coronary artery disease (%) 66 50 .02
Diabetes mellitus (%) 33 33 NS
Hyperlipidemia (%) 31 30 NS
Continued smoking (%) 70 54 .03
Renal failure (%) 16 11 NS
Warfarin therapy (%) 45 41 NS
Aspirin therapy (%) 65 67 NS
Extraanatomic PI (%) 50 43 NS
Prior outflow procedure (%) 29 27 NS
Alternative vein conduit (%) 19 19 NS
Infrapopliteal AIB target (%) 40 45 NS
Limb salvage indication (%) 97 88 .05
Simultaneous PI and AIB (%) 66 70 NS
PI, Prosthetic inflow; AIB, autogenous infrainguinal bypass; NS, not signif-
icant.
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originated from the proximal superficial femoral artery, and
6 (3%) originated from the common femoral artery in the
groin
Perioperative mortality and inguinal wound com-
plications. The incidence of perioperative mortality and
inguinal wound complications was not statistically different
between the two groups. In group 1 there were three (5%)
perioperative deaths and seven (12%) inguinal wound com-
plications, including inguinal infection requiring operative
debridement in one patient, inguinal seromas requiring
operative drainage in four patients, and inguinal infections
treated with intravenous antibiotic agents in three patients.
In Group 2 there were six (3.5%) perioperative deaths and
22 (13%) inguinal wound complications, including ingui-
nal infections requiring operative debridement in eight
patients, inguinal hematomas requiring operative drainage
in two patients, inguinal seromas requiring operative drain-
age in four patients, and inguinal infections treated with
intravenous antibiotic agents in eight patients.
Types of inflow graft and patency. The types of PI
between the two groups were not statistically different
(Table II). In Group 1 the PI was aortofemoral in 23%,
iliofemoral in 19%, femorofemoral in 16%, axillounifemoral
in 9%, and axillobifemoral in 33%. In Group 2 the PI was
aortofemoral in 25%, iliofemoral in 26%, femorofemoral in
18%, axillounifemoral in 10%, and axillobifemoral in 21%.
The 5-year assisted primary patency rate for all inflow
grafts was 53% in group 1 and 68% in group 2 (P  .003).
Concurrent PI and AIB occlusion. During follow-
up, 30 AIB thromboses and 26 PI occlusions occurred in
group 1, and 30 AIB thromboses and 36 PI occlusions
occurred in group 2. In group 1, four patients had more
than one AIB thrombosis event and three patients had
more than one PI occlusion event. In group 2, two patients
had more than one AIB thrombosis event and six patients
had more than one PI occlusion event.
The native inflow to the groin was occluded in 12
(63%) group 1 patients with PI occlusions and 19 (73%)
group 2 patients with PI occlusions. The native inflow to
the groin was marginally preserved through a diffusely
stenotic iliac system in seven (37%) group 1 patients with PI
occlusions and seven (27%) group 2 patients with PI occlu-
sions (P  NS).
In group 1, 23 (89%) AIBs became thrombosed con-
current with 26 PI occlusions. In group 2, 7 (19%) AIBs
thrombosed concurrent with 36 PI occlusions (P  .004).
In 8 (35%) episodes of concurrent AIB and PI occlusions in
group 1 and 3 (43%) episodes in group 2 the native inflow
was persistent through diffusely stenotic iliac vessels (P 
NS). Conversely, 7 of 30 (23%) AIB thrombosis events in
group 1 were not associated with PI occlusion, compared
with 23 of 30 (77%) AIB thrombosis events in group 2 (P
.028).
Kaplan-Meier analysis. With the Kaplan-Meier
method, in group 1 the 5-year assisted primary patency rate
was 50%, limb salvage rate was 78%, and survival rate was
63%. In group 2 the 5-year assisted primary patency rate
was 75%, limb salvage rate was 90%, and survival rate was
69%. With log-rank comparison, the difference in assisted
primary patency rate (group 1, 50%; group 2, 75%; P 
.001) and limb salvage rate (group 1, 78%; group 2, 90%; P
 .005) was statistically significant. Comparison of Kaplan-
Meier–derived patient survival rates showed no difference
between the two groups (Tables III-V).
During follow-up, 27% (17) of AIBs in group 1 re-
quired a mean of 1.4 revisions to maintain assisted primary
patency, compared with 28% (56) of AIBs in group 2,
which required a mean of 1.3 revisions (P  NS). Twenty-
four AIB revisions were performed in group 1, and 73 AIB
revisions were performed in group 2. In group 1, 75% (18)
of AIB revisions included the proximal anastomosis, 10%
(2) involved only the graft, and 15% (4) included the distal
anastomosis. In group 2, 37% (27) of AIB revisions in-
cluded the proximal anastomosis, 30% (22) involved only
the graft, and 33% (24) included the distal anastomosis (P
 .01).
Independent factors associated with graft occlu-
sion. Factors included in the Cox proportional hazards
model are listed in Table VI. Factors that were not signifi-
cantly associated with AIB occlusion were age, gender,
coronary artery disease, diabetes mellitus, hyperlipidemia,
renal failure, postoperative aspirin therapy, extraanatomic
PI, repeat operation, simultaneous PI and AIB, alternative
vein conduit, infrapopliteal AIB target, operative indica-
tion, and patency of the ipsilateral profunda femoris artery.
There was a strong association of continued smoking with
AIB occlusion (P  .08). Hypertension, postoperative
warfarin therapy, PI occlusion, and location of the proximal
AIB anastomosis directly on the PI were significant inde-
pendent risk factors for AIB occlusion. HR for those factors
associated with AIB occlusion are listed in Table VII.
DISCUSSION
Patients with lower extremity ischemia resulting from
multilevel arterial occlusive disease are more likely to have
limb-threatening ischemia and more comorbid conditions
compared with patients with single level arterial occlusive
disease.3,10 Previous studies regarding multilevel athero-
sclerotic occlusive disease have focused on the timing of
inflow and outflow reconstruction. A staged approach in
which inflow reconstruction is performed first and outflow
reconstruction is performed in patients with persistent isch-
emic symptoms has been advocated by some authors.2,16-19
Other studies have promoted simultaneous repair of inflow
Table II. Type of prosthetic inflow procedure
Type of prosthetic
inflow
Group 1
(n  59)
Group 2
(n  170)
Aortofemoral (%) 23 25
Iliofemoral (%) 19 26
Femorofemoral (%) 16 18
Axillounifemoral (%) 9 10
Axillobifemoral (%) 33 21
P  not significant for all pairs.
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and outflow occlusive disease to decrease the morbidity of
multiple operations.3,10,20,21 The outcome of infrainguinal
bypass procedures in patients with inflow reconstruction
has been good.1,11,22
A critical surgical decision is required when the PI
terminates and the AIB originates in the ipsilateral groin.
The anastomosis between the PI and AIB can be in conti-
nuity or the anastomoses can be separated with a segment
of native artery. Placement of the AIB proximal anastomo-
sis on a distal native artery requires meticulous dissection of
the groin, especially in patients who have undergone pre-
vious revascularization procedures involving the inguinal
vessels. When using a distal native vessel as the origin of
infrainguinal bypass grafts, the vessel with the best appear-
ance at angiography is chosen. In this study we retrospec-
tively reviewed records for 229 patients who had both PI
and AIB with anastomoses in the groin, to compare the
outcome of AIBs with the proximal anastomosis in conti-
nuity with the PI and those with the proximal anastomosis
originating more distally on a native vessel, and also to
identify independent risk factors for AIB occlusion in this
population of patients.
Consistent with previous reports,10,11 patients in this
study were elderly, predominantly male, and had a high
incidence of hypertension, continued smoking, and coro-
nary artery disease. Hypertension, warfarin therapy, PI
occlusion, and location of the proximal AIB anastomosis in
continuity with the PI were identified as independent risk
factors for AIB occlusion. Although not statistically signif-
icant, there was a trend toward an association between
continued smoking and AIB occlusion (P  .08).
The association of atherosclerosis progression and hy-
pertension is well-established.23,24 Potential mechanisms
of this association involve the proinflammatory effects of
hypertension on the artery, resulting in recruitment of
monocytes into the intima and generation of oxygen free
radicals. The free radicals may stimulate genes within the
vascular endothelium that recruit inflammatory cells. Pa-
Table III. Assisted primary patency of autogenous infrainguinal bypass procedures
Interval
(mo) At risk Occluded Withdrawn
Cumulative patency
rate SEM
Group 1 0 64 5 4 0.92 0.03
6 55 8 14 0.77 0.06
12 33 2 7 0.72 0.08
24 24 3 4 0.62 0.08
36 17 0 2 0.62 0.08
48 15 1 5 0.58 0.08
60 9 1 2 0.50 0.10
Group 2 0 200 2 9 0.99 0.01
6 189 6 45 0.95 0.02
12 138 7 15 0.90 0.02
24 116 7 27 0.84 0.03
36 82 3 10 0.81 0.04
48 69 4 8 0.76 0.04
60 57 1 13 0.75 0.04
P  .001, log-rank test.
Table IV. Limb salvage data
Interval
(mo) At risk Amputated Withdrawn
Cumulative limb
salvage rate SEM
Group 1 0 59 2 4 0.97 0.03
6 53 4 16 0.89 0.06
12 33 0 8 0.89 0.08
24 25 3 6 0.78 0.08
36 16 0 3 0.78 0.08
48 14 0 7 0.78 0.09
60 7 0 0 0.78 0.10
Group 2 0 172 3 7 0.98 0.01
6 162 1 49 0.97 0.01
12 112 2 15 0.96 0.02
24 95 2 27 0.93 0.02
36 66 1 10 0.92 0.03
48 55 1 5 0.90 0.03
60 49 0 17 0.90 0.03
P  .005, log-rank test.
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tients with multilevel atherosclerotic occlusive disease, by
definition, have severe atherosclerosis, and have been sug-
gested to have an increased rate of atherosclerotic disease
progression.2,4
Cigarette smoking and the presence of a relative hyper-
coagulable state requiring warfarin therapy are docu-
mented risk factors for decreased graft patency and progres-
sion of arterial occlusive disease.8,25-27 In a prospective
study, Greenhalgh et al28 demonstrated that elevated blood
level of carboxyhemoglobin was associated with arterial
graft occlusion. The importance of smoking cessation
should be stressed at each patient encounter. With regard
to warfarin therapy, it is also possible that patients may have
been given warfarin because they were thought to be at
high risk for graft occlusion. The effectiveness of warfarin in
preventing AIB occlusion cannot be ascertained from this
study, because there was no comparative group of patients
at risk for graft occlusion in whom warfarin was not admin-
istered. In this situation postoperative warfarin therapy
merely indentifies patients at higher risk for graft thrombo-
sis.
A proximal AIB anastomosis in continuity with the PI,
and PI occlusion were associated with AIB occlusion in
patients requiring both inflow and outflow reconstruction.
These were independent of atherosclerotic risk factors,
technical factors of the infrainguinal reconstruction, and
patency of the profunda femoris artery. In the incidences of
concurrent PI and AIB occlusion, it is unknown whether PI
occlusion caused AIB occlusion or AIB occlusion caused PI
occlusion. Although a cause-and-effect relationship cannot
be determined, PI occlusion was identified in the multivar-
iate analysis as an independent risk factor associated with
AIB occlusion.
In this retrospective study a proximal AIB anastomosis
in continuity with PI is likely to be a marker for unfavorable
inguinal anatomy, and a technical risk factor for decreased
AIB patency. Retrospective review of preoperative angio-
grams to determine the patency of the ipsilateral profunda
femoris artery was performed in an effort to determine
whether the profunda femoris artery was available for the
proximal anastomosis of the AIB. A prospective, random-
ized study comparing the site of proximal AIB anastomosis
Table V. Patient survival data
Interval
(mo) At risk Dead Withdrawn
Cumulative survival
rate SEM
Group 1 0 59 0 2 1.00 0.00
6 57 1 6 0.98 0.02
12 50 4 4 0.90 0.04
24 42 3 5 0.83 0.05
36 34 3 3 0.75 0.07
48 28 1 2 0.73 0.07
60 25 5 5 0.56 0.08
Group 2 0 170 0 2 1.00 0.00
6 168 0 10 1.00 0.00
12 158 4 4 0.97 0.01
24 150 13 16 0.88 0.03
36 121 10 12 0.81 0.03
48 99 10 5 0.72 0.04
60 84 3 13 0.69 0.04
P  not significant, log-rank test.
Table VI. Factors analyzed with Cox proportional
hazards model
Age
Gender
Hypertension
Coronary artery disease
Diabetes mellitus
Hyperlipidemia
Continued smoking
Renal failure
Postoperative warfarin therapy
Postoperative aspirin therapy
Extraanatomic PI
Previous outflow procedure
Alternative vein conduit
Infrapopliteal AIB target
Limb salvage indication
Simultaneous PI and AIB
AIB arising from PI
Patency of ipsilateral profunda femoris artery
PI patency
PI, Prosthetic inflow; AIB, autogenous infrainguinal bypass.
Table VII. Hazards ratios for graft occlusion calculated
with Cox proportional hazards model
Patient factor
Hazard
ratio 95% CI P
Hypertension 3.41 1.65–7.05 .001
Postoperative warfarin
therapy
1.86 1.07–3.23 .03
Continued smoking 1.72 0.93–3.18 .08
AIB arising from PI 2.38 1.35–4.18 .003
PI occlusion 3.70 2.15–6.36 .001
AIB, Autogenous infrainguinal bypass; PI, prothetic inflow; CI, confidence
interval.
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in patients with PI extending into the inguinal vessels is
required to definitively determine whether a continuous PI
and AIB anastomosis leads to increased AIB occlusion.
The decreased patency of AIBs and PIs in group 1 can
be attributed to the increased tendency of concurrent in-
flow and outflow occlusions when the PI and AIB are in
direct communication. A segment of native artery that can
remain patent, with a small amount of collateral flow, may
diminish the risk for concurrent inflow and outflow throm-
boses. While dissection of native distal arteries is often more
tedious and time-consuming, use of native artery as the
proximal anastomotic site of an AIB provides significant
benefit in long-term outcome, with no increase in morbid-
ity.
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DISCUSSION
Dr Gregorio A. Sicard (St Louis, Mo). I do have a technical
question. Usually our inflow grafts end up fairly far down in the
common femoral arteries, sometimes extending to the proximal
profunda. Where are you placing these i infrainguinal bypasses in
the native artery group?
Dr Everett Y. Lam. Usually it’s a centimeter or two distal to
the prosthetic inflow.
Dr Sicard. So you’re using SFA, the superficial femoral artery,
or primarily the profunda as your native inflow?
Dr Lam. In this study, 85% of the patients had an infraingui-
nal bypass originating off the profunda; 12% originated off of the
superficial femoral artery; and 3% originated off of a more distal
common femoral artery.
Dr George Louridas (Winnipeg, Canada). Your group is well
known in that they believe in the reverse vein group and not the in
situ vein group. Do you think, when you use a reverse vein group,
it’s a smaller vein anastomosis to the prosthetic, and that might be
a factor? Whereas if you had to do an in situ, you’d have a bigger
vein on your prosthetic, and that might change things?
Dr Lam. We have no comparison to make that decision,
because we do not do in situ vein grafts. But that may be a reason.
We cannot make any associations with that statement.
Dr Gary W. Gibbons (Boston, Mass). Along that line, did
you do any of these grafts in a nonreversed manner? You said you
didn’t do them in situ. But did you do any in a nonreversed
manner, where you cut the valves, so that the bigger end of the vein
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was into the proximal bigger artery? I share the same concerns that
if you have the smaller end into a prosthetic graft, that may affect
the outcome.
Dr Lam. Unfortunately, again our preference is to do reverse
saphenous vein grafts. All the patients in this series had reverse
saphenous vein grafts, and I cannot make that comparison.
Dr Geun Eun Kim (Seoul, Korea). Smoking is one of the
biggest risk factors for limb patency. And you have a higher
incidence of smoking in the group with the anastomosis at the graft
portion. Do you have data that exclude smokers in each group and
compare the patency?
Dr Lam. We did not exclude it, but we included it in our
multivariate analysis to determine if there was an independent
association between continued cigarette smoking and infrainguinal
graft occlusion.
Dr Kim. I think to compare that you may have to exclude that
separate group.
Dr John Blebea (Hershey, Pa). I congratulate you on a very
nice study, but I’m concerned that you’re really comparing two
very different patient populations. Did you separately examine
those patients with a patent profunda that had the proximal
anastomosis originate from the native PFA compared with patients
with a smilar patent PFA but the anastomosis was from the hood of
the prosthetic inflow limb?
You looked at the group as a whole, and found that a greater
number of patients with a patent PFA had the proximal anastomo-
sis from that vessel, which makes sense. If the profunda was severely
diseased or occluded you would not use it as a source for inflow. In
these types of patients, with more severe disease, one would use the
prosthetic inflow graft for the proximal anastomosis, but would
then expect their long-term outcomes to be worse. To compare
similar groups, you should analyze just the patients with an open
PFA, with and without the proximal anastomosis on the prosthetic
graft, and see if their patency rates were different. Did you do that
comparison, and do the results remain unchanged?
My second question regards the poor patency rates of your
inflow grafts, which are only 70% to 75%. Was there a greater
proportion of axillofemoral bypasses in the patient population with
a prosthetic proximal anastomosis?
Dr Lam. With regard to your first question, whether bypass
graft, comparing occluded profunda with not occluded, I did do
that subgroup analysis. And the patency rate remained the same.
With respect to the second question, 42% of group 1 patients
and 31% of group 2 patients had axillofemoral grafts and axillob-
ifemoral grafts. This difference was not statistically significant.
Dr Enrico Ascher (Brooklyn, NY). I just rise to offer another
option that may avoid complications in the groin, such as lymphor-
rhea infection, which is the use of the external iliac artery as a
primary inflow in these situations. We have had excellent experi-
ence with this approach, with almost near zero complication rates
in the groin. Isn’t that easier to use than to go on a redo groin and
try to dig the profunda?
Dr Lam. Typically when our patients have multiple repeat
operations and their external iliac arteries are diseased, these are
replaced with the iliofemoral grafts. In this study we considered
that as an inflow graft to our infrainguinal bypass grafts. So
occasionally there were some patients who had infrainguinal bypass
grafts coming off of the iliofemoral graft that replaced the diseased
external iliac bypass.
Dr Sachinder S. Hans (Warren, Mich). Is it possible that
some of your grafts occluded in prosthetic origin, particularly
because of the outflow? You didn’t mention anything to us about
your outflow position.
And the second question I have is that many times I find it very
difficult to bring the origin of the graft from the superficial femoral
artery. In many cases what I have done is opened the prosthetic
graft, put a patch on it, and then applied the vein graft over the
patch.
Dr Lam. With regard to your first question, an infrapopliteal
target was included in our multivariate analysis. An infrapopliteal
target was used in 40% of group 1 patients and 45% of group 2
patients. So that was included in our multivariate analysis, and that
did not come out as an independent risk factor.
Dr Jose Alvarez (Miami, Fla). I have a technical question. Did
you look at how many people had a local endarterectomy of the
artery as the site of a donor distal bypass in your group?
Dr Lam. In this paper we did not consider endarterectomy as
an inflow procedure. We have had many patients who have had
endarterectomies for infrainguinal bypass graft, coming off of that,
but that was not included in this paper. This paper was specifically
looking at prosthetic inflow grafts and autogenous infrainguinal
bypass grafts.
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